WEDNESDAY, Aug. 2, 2023 (HealthDay News) -- A six-month aerobic exercise intervention significantly improves self-reported chemotherapy-induced peripheral neuropathy (CIPN) among patients treated for ovarian cancer, according to a study published online Aug. 1 in JAMA Network Open.
Anlan Cao, M.B.B.S., from Yale University in New Haven, Connecticut, and colleagues evaluated the effect of a six-month aerobic exercise intervention on CIPN among women treated for ovarian cancer. The analysis included 134 participants in the Women's Activity and Lifestyle Study in Connecticut (65 controls).
The researchers found that at six months, the self-reported CIPN score was 1.3 points lower in the exercise intervention arm (95 percent confidence interval, −2.3 to −0.2) versus an increase of 0.4 points in the attention control arm (95 percent confidence interval, −0.8 to 1.5). The between-group difference was −1.6 points (95 percent confidence interval, −3.1 to −0.2). Among participants with CIPN symptoms at baseline, the point estimate was larger (−2.0; 95 percent confidence interval, −3.6 to −0.5).
"While replication of the findings in other studies is warranted, incorporating referrals to exercise programs into standard oncology care could reduce CIPN symptoms and increase quality of life in patients with ovarian cancer," the authors write.
(0) comments
Welcome to the discussion.
Log In
Keep it clean. Please avoid obscene, vulgar, lewd, racist or sexual language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't threaten. Threats of harming another person will not be tolerated.
Be truthful. Don't knowingly lie about anyone or anything.
Be nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be proactive. Use the "Report" link on each comment to let us know of abusive posts.
Share with us. We'd love to hear eyewitness accounts, the history behind an article.